LINC00960 and breast carcinoma: We subsequently validated the correlation between LINC00960 and the eight miRNAs expression using the ENCORI database and identified hsa-miR-16-5p, hsa-miR-183-5p, and hsa-miR-34a-5p as potential targets for LINC00960 in breast cancer.